Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Psoriatic Arthritis

In brief

This study has been designed to explore the clinical efficacy and safety of HS-10374 in the treatment of active psoriatic arthritis. Additionally, this study is to find the optimal dosing for the future clinical development of HS-10374.

Key facts

Study ID
NCT06176508
Run by
Hansoh BioMedical R&D Company
People needed
160
Starts
2024-02-26
Expected to finish
2026-08-28
Last updated by the study team
2024-07-18

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.